UK budget includes £1bn biopharma investment package
UK Chancellor John Healey's first Budget speech included a £1bn-plus industry investment package at sites in Manchester, Oxford, and Loughborough.
Newsletters and Deep Dive digital magazine
UK Chancellor John Healey's first Budget speech included a £1bn-plus industry investment package at sites in Manchester, Oxford, and Loughborough.
Regulators define a rare disease by how many people have it, and the answer depends on who is counting.
Egetis has launched the first-ever therapy for the ultra-rare disease MCT8 deficiency in the US, with a list price of $950,000 per year.
US policy changes designed to curb drug prices seem ineffective, as the annual cost of new medicines still exceeds $250,000, curbing patient access.
Researchers have developed an AI model, trained on millions of facial images, that can directly predict survival risk in patients with cancer.
Editor's Picks
Newsletters and Deep Dive
digital magazine